K-V Pharmaceutical reports operating income of $1.76 million in March

By Jim Witters

Wilmington, Del., April 16 - K-V Pharmaceutical Co. posted operating income of $1.76 million for March on net revenue of $7.06 million, according to the company's monthly operating report filed April 16 with the U.S. Bankruptcy Court for the Southern District of New York.

Those figures compare to operating income of $572,000 for February on $6.38 million in net revenue.

The net loss from continuing operations was $1.14 million in March, compared to $4.91 million in February.

The company also reported cash and cash equivalents of $37.25 million as of March 31, compared to $34.25 million at the end of February.

K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4, 2012. The Chapter 11 case number is 12-13346.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.